Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Health Affairs (Project Hope)|November 1, 2021
Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial MedicinesKevin OuttersonHealth Affairs (Project Hope)|May 4, 2016
Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive PolicyKevin Outterson, Anthony McDonnellHealth Affairs (Project Hope)|September 8, 2010
Fighting antibiotic resistance: marrying new financial incentives to meeting public health goalsAaron S Kesselheim, Kevin OuttersonHealth Affairs (Project Hope)|January 9, 2008
Market-based licensing for HPV vaccines in developing countriesKevin Outterson, Aaron S KesselheimThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 6, 2015
What Will It Take to Address the Global Threat of Antibiotic Resistance?Steven J Hoffman, Kevin OuttersonHealth Affairs (Project Hope)|August 1, 2009
How Medicare could get better prices on prescription drugsKevin Outterson, Aaron S KesselheimTranslational Research : the Journal of Laboratory and Clinical Medicine|March 14, 2020
Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercializationKevin Outterson, John H RexThe Lancet. Infectious Diseases|April 3, 2016
Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approachJohn H Rex, Kevin OuttersonThe Milbank Quarterly|August 28, 2025
Policy Options for Antimicrobial Resistance: Exploring Lessons From Environmental GovernanceIsaac Weldon, Kathleen Liddell, Kevin OuttersonPageof 5